37% Etching Gel-5ml syringe, part #N01IB The intended use of these devices is to etch tooth dentin/enamel in order to pr
FDA device recall Z-0157-2012 · posted 2011-11-03 · Terminated
Recall details
- Recalling firm
- Kerr/pentron Dba Kerr Corporation And Pentron Clinical
- Reason for recall
- Pentron Clinical is voluntarily recalling all lots of products labeled as 37% Phosphoric Acid Etching Gel produced since April 2007 because the product continues to extrude out of the syringe even after pressure is no longer applied, and it contains a higher percentage of phosphoric acid than that indicated on the label.
- Action taken
- The firm, Pentron Clinical, sent an "URGENT: MEDICAL DEVICE RECALL" letter dated May 31, 2011, with attached Return Form (via USPS 1st class mail) to all their consignees/customers. The letter describes the product, problem and action to be taken. All consignees/customers were instructed to complete the Recall Return Form via fax to: 1-877-677-8844 and to return any affected product in their inventory. Affected products will have expiration dates between April 2011 and April 2015. Consignees/customers with questions can contact Pentron Clinical Customer Service at (800) 551-0283 directly to handle the arrangements of a quick return and replacement.
- Root cause
- Nonconforming Material/Component
- Status
- Terminated
- Product code
- EBF
- Quantity affected
- 41,744 units
- Distribution
- Worldwide distribution: USA (nationwide) and countries of: Armenia, Austria, Australia, Antigua & Barbuda, Barbados, Belarus, Bulgaria, Canada, Czech Republic, Croatia, Cyprus, Ecuador, El Salvador, F
- Date initiated
- 2011-03-31
- Date posted
- 2011-11-03
- Date terminated
- 2012-08-09
- Location
- Orange, CA
Monitor recalls programmatically
Recalls and clearances share one API, with change alerts when new recalls post.
Related 510(k) clearances
| Record | Firm | Date |
|---|---|---|
| DUAL-CURE RADIOPAQUE (K874189) | Pentron Corp. | 1988-02-11 |